Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if she will make an assessment of the potential impact of her Department's decision to exclude people aged between 66 and 69 on 1 September 2023 who do not have a severely weakened immune system in the phased roll-out of the shingles vaccination on those people.

An assessment on the potential impact of not providing the vaccine to people aged 66 to 69 years old is not required, as they remain eligible to receive a shingles vaccination when they turn 70 years old, as they would have done prior to 1 September 2023.

The current policy offers the shingles vaccine Shingrix to anyone who turned 65 or 70 years old on or after 1 September 2023, and to anyone aged 50 years old and over who is at higher risk of serious complications as a result of having a severely weakened immune system.

This approach has been used in the effective implementation of previous immunisation programmes. Whilst some individuals may have to wait until they are eligible, the population benefit of adopting this approach is greater, meaning many individuals will receive the vaccine sooner and will benefit for longer.

The approach is modelled on the first shingles programme, optimizing achievements within the resources and capacity of the National Health Service, while being delivered alongside other important healthcare priorities, and avoiding undue additional pressure on NHS delivery services.